Pfizer has partnered with Summit Therapeutics to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with ...

The hiring of a former top FDA official amplifies "revolving door" criticism at the worst possible time, STAT's Adam ...

Pfizer on Monday named the former head of the U.S. health regulator's drug evaluation unit, Patrizia Cavazzoni, as its chief ...

Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the TD Cowen 45 th Annual Health ...

Pfizer CEO Dr. Albert Bourla was loudly booed during a White House Black History Month event where he was introduced by President Trump.

Trump Ignites Controversy at Black History Month Event** Amidst the backdrop of a politically charged climate, President Donald Trump recently found himself i ...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...

Pfizer may appeal to income investors, but growth prospects remain uncertain. Read why PFE stock might struggle to gain ...

The future of the CDC’s vaccine advisory committee seems uncertain: A scheduled February meeting for the ACIP, which advises ...

President Donald Trump's introduction of a Pfizer executive at the White House Wednesday was met with a roar of boos from the crowd.

US President Donald Trump was joined by golfer Tiger Woods for an event marking Black History Month Thursday -- even as his ...

The meeting, which will include Pfizer CEO Albert Bourla as the newly named board of directors’ chair, will reportedly cover ...